Vizora日本語

Sumitomo ChemicalSUMITOMO CHEMICAL COMPANY, LIMITED4005東証プライム化学FY ending Mar 2026, consolidated, IFRS

Sumitomo Chemical FY ending Mar 2022 results

About 23% of Sumitomo Chemical's sales come from Petrochemistry, with Essential Chemicals and Plastics and Medical products making up much of the rest.

Out of every ¥100 of sales, about ¥8 is left as operating profit.

Revenue changed +20.9% from the prior year, operating profit +56.8%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +20.9% · profit +56.8%, calculated from disclosed figures.

Operating leverage: 2.72× (profit growth ÷ revenue growth)

What changed from last year

FY ending Mar 2021 → FY ending Mar 2022

Revenue
+20.9%¥2.29T → ¥2.77T
Gross profit
+13.3%¥771.2B → ¥873.9B
Operating income
+56.8%¥137.1B → ¥215B
Net income attributable to owners
+252.1%¥46B → ¥162.1B
Operating cash flow
-54.1%¥374.5B → ¥171.7B

Where the money goes

FY ending Mar 2021 → FY ending Mar 2022

※ Segment revenues include inter-segment sales and are scaled to consolidated revenue

Where ¥100 of sales goes

For every ¥100 Sumitomo Chemical sells, how much goes where, and how much is kept.

FY ending Mar 2022
Cost of sales
¥68
SG&A
¥25
Other costs
¥1
Operating profit
¥8
Net profit kept
¥6

Annual margin trends

Gross margin31.6%
FY ending Mar 2020: 31.8%31.8%FY ending Mar 2021: 33.7%33.7%FY ending Mar 2022: 31.6%31.6%FY17FY18FY19FY20FY21FY22
Operating margin7.8%
FY ending Mar 2020: 6.2%6.2%FY ending Mar 2021: 6.0%6.0%FY ending Mar 2022: 7.8%7.8%FY17FY18FY19FY20FY21FY22
Net margin5.9%
FY ending Mar 2017: 3.9%3.9%FY ending Mar 2018: 6.1%6.1%FY ending Mar 2019: 5.1%5.1%FY ending Mar 2020: 1.4%1.4%FY ending Mar 2021: 2.0%2.0%FY ending Mar 2022: 5.9%5.9%FY17FY18FY19FY20FY21FY22

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2022
  • Petrochemistry¥842.5B
    23%
    Op. margin 6.4%
  • Essential Chemicals and Plastics¥842.5B
    23%
    Op. margin 6.4%
  • Medical products¥591.7B
    16%
    Op. margin 10.4%
  • Health and agriculture related¥473.8B
    13%
    Op. margin 8.9%
  • Information electronic chemistry¥473.7B
    13%
    Op. margin 12.2%
  • Energy and functional materials¥316.4B
    9%
    Op. margin 6.3%
  • Other¥67.2B
    2%
    Op. margin 23.5%

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第145期(2025/04/01－2026/03/31)

    ID S100YAUO2026-06-22Open

  • EDINET (FSA Japan)

    有価証券報告書－第144期(2024/04/01－2025/03/31)

    ID S100VXZW2025-06-20Open

  • EDINET (FSA Japan)

    有価証券報告書－第143期(2023/04/01－2024/03/31)

    ID S100TMMW2024-06-21Open

  • EDINET (FSA Japan)

    有価証券報告書－第142期(2022/04/01－2023/03/31)

    ID S100QXTB2023-06-21Open

  • EDINET (FSA Japan)

    有価証券報告書－第141期(令和3年4月1日－令和4年3月31日)

    ID S100O9HK2022-06-23Open

  • EDINET (FSA Japan)

    有価証券報告書－第140期(令和2年4月1日－令和3年3月31日)

    ID S100LJNG2021-06-23Open

Extracted from XBRL: 42

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image